直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.

Dow Pharmaceutical Sciences, Inc.; Valeant

Taro Pharmaceuticals U.S.A., Inc.

Represented Dow and Valeant in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic versions of Onexton®.

Dow Pharmaceutical Sciences, Inc.; Valeant v. Taro Pharmaceuticals U.S.A., Inc., 2:16-cv-00217; 2:17-cv-00544, -01568, D.N.J., Judges Chesler, Waldor

Related Professionals

Bryan C. Diner
Partner
Washington, DC
+1 202 408 4116
Email
Justin J. Hasford
Partner
Washington, DC
+1 202 408 4175
Email
Matthew J. Hlinka
Partner
Washington, DC
+1 202 408 4333
Email
Chiaki Kobayashi
Partner
Tokyo
+ 813 3 431 6525
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.

Dow Pharmaceutical Sciences, Inc.

Dow Pharmaceutical Sciences, Inc. v. Actavis, Inc. 

Dow Pharmaceutical Sciences, Inc.

Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc. 

Valeant; Salix; Progenics

Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.

Medicis Pharmaceutical Corp.

Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.

Valeant Pharmaceuticals North America, LLC

Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.

Elan Pharmaceuticals, Inc.

Finnegan secures 10 years of patent protection for Relistor®

Valeant; Salix; Progenics

Wyeth v. Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.

Wyeth

Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.

Medicis Pharmaceutical Corp.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP